Mission Creek Capital Partners Inc. Has $1.75 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mission Creek Capital Partners Inc. raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,563 shares of the medical equipment provider’s stock after purchasing an additional 342 shares during the period. Mission Creek Capital Partners Inc.’s holdings in Intuitive Surgical were worth $1,750,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical in the second quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. LGT Financial Advisors LLC boosted its holdings in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ISRG has been the topic of several research analyst reports. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Raymond James increased their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Finally, Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $522.00 to $650.00 in a research note on Monday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $536.61.

Insider Buying and Selling at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 51,023 shares of company stock valued at $26,384,247. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $541.71 on Wednesday. The firm has a market cap of $192.95 billion, a PE ratio of 87.09, a P/E/G ratio of 5.34 and a beta of 1.38. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $552.00. The stock has a fifty day moving average price of $512.25 and a 200-day moving average price of $471.53.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.